世界のモノクローナル抗体療法市場インサイト及び予測(~2026年)

【英語タイトル】Global Monoclonal Antibody Therapy Market Size, Status and Forecast 2020-2026

QYResearchが出版した調査資料(QYR20NV03847)・商品コード:QYR20NV03847
・発行会社(調査会社):QYResearch
・発行日:2020年11月(※2024年版があります。お問い合わせください)
・ページ数:92
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートはモノクローナル抗体療法の世界市場について調査・分析した資料です。種類別(組換え、キメラ、ヒト化、ヒト)の市場規模、用途別(診断検査、分析および化学、癌治療、自己免疫疾患、造血系疾患)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別モノクローナル抗体療法の競争状況、市場シェア
・世界のモノクローナル抗体療法市場:種類別市場規模 2015年-2020年(組換え、キメラ、ヒト化、ヒト)
・世界のモノクローナル抗体療法市場:種類別市場規模予測 2021年-2026年(組換え、キメラ、ヒト化、ヒト)
・世界のモノクローナル抗体療法市場:用途別市場規模 2015年-2020年(診断検査、分析および化学、癌治療、自己免疫疾患、造血系疾患)
・世界のモノクローナル抗体療法市場:用途別市場規模予測 2021年-2026年(診断検査、分析および化学、癌治療、自己免疫疾患、造血系疾患)
・北米のモノクローナル抗体療法市場分析:米国、カナダ
・ヨーロッパのモノクローナル抗体療法市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのモノクローナル抗体療法市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のモノクローナル抗体療法市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのモノクローナル抗体療法市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Abbvie、Amgen、Glaxosmithkline、Merck、Novartis
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages.
Therapeutic monoclonal antibodies act through multiple mechanisms, such as blocking of targeted molecule functions, inducing apoptosis in cells which express the target, or by modulating signaling pathways. One possible treatment for cancer involves monoclonal antibodies that bind only to cancer cell-specific antigens and induce an immune response against the target cancer cell.In addition, monoclonal antibodies used for autoimmune diseases include infliximab and adalimumab, which are effective in rheumatoid arthritis, Crohn’s disease, ulcerative colitis and ankylosing spondylitis by their ability to bind to and inhibit TNF-α.

Market Analysis and Insights: Global Monoclonal Antibody Therapy Market
The global Monoclonal Antibody Therapy market size is projected to reach US$ 117720 million by 2026, from US$ 109280 million in 2020, at a CAGR of 7.1%% during 2021-2026.

Global Monoclonal Antibody Therapy Scope and Market Size
Monoclonal Antibody Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Monoclonal Antibody Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Abbvie
Amgen
Glaxosmithkline
Merck
Novartis

Market segment by Type, the product can be split into
Recombinant
Chimeric
Humanized
Human
Market segment by Application, split into
Diagnostic Test
Analytical And Chemical Uses
Cancer Treatment
Autoimmune Diseases
Hematological Disorders

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Monoclonal Antibody Therapy Revenue
1.4 Market by Type
1.4.1 Global Monoclonal Antibody Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Recombinant
1.4.3 Chimeric
1.4.4 Humanized
1.4.5 Human
1.5 Market by Application
1.5.1 Global Monoclonal Antibody Therapy Market Share by Application: 2020 VS 2026
1.5.2 Diagnostic Test
1.5.3 Analytical And Chemical Uses
1.5.4 Cancer Treatment
1.5.5 Autoimmune Diseases
1.5.6 Hematological Disorders
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Monoclonal Antibody Therapy Market Perspective (2015-2026)
2.2 Global Monoclonal Antibody Therapy Growth Trends by Regions
2.2.1 Monoclonal Antibody Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Monoclonal Antibody Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Monoclonal Antibody Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Monoclonal Antibody Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Monoclonal Antibody Therapy Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Therapy Players by Market Size
3.1.1 Global Top Monoclonal Antibody Therapy Players by Revenue (2015-2020)
3.1.2 Global Monoclonal Antibody Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Monoclonal Antibody Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Monoclonal Antibody Therapy Market Concentration Ratio
3.2.1 Global Monoclonal Antibody Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Therapy Revenue in 2019
3.3 Monoclonal Antibody Therapy Key Players Head office and Area Served
3.4 Key Players Monoclonal Antibody Therapy Product Solution and Service
3.5 Date of Enter into Monoclonal Antibody Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Monoclonal Antibody Therapy Historic Market Size by Type (2015-2020)
4.2 Global Monoclonal Antibody Therapy Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Monoclonal Antibody Therapy Market Size by Application (2015-2020)
5.2 Global Monoclonal Antibody Therapy Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Monoclonal Antibody Therapy Market Size (2015-2020)
6.2 Monoclonal Antibody Therapy Key Players in North America (2019-2020)
6.3 North America Monoclonal Antibody Therapy Market Size by Type (2015-2020)
6.4 North America Monoclonal Antibody Therapy Market Size by Application (2015-2020)

7 Europe
7.1 Europe Monoclonal Antibody Therapy Market Size (2015-2020)
7.2 Monoclonal Antibody Therapy Key Players in Europe (2019-2020)
7.3 Europe Monoclonal Antibody Therapy Market Size by Type (2015-2020)
7.4 Europe Monoclonal Antibody Therapy Market Size by Application (2015-2020)

8 China
8.1 China Monoclonal Antibody Therapy Market Size (2015-2020)
8.2 Monoclonal Antibody Therapy Key Players in China (2019-2020)
8.3 China Monoclonal Antibody Therapy Market Size by Type (2015-2020)
8.4 China Monoclonal Antibody Therapy Market Size by Application (2015-2020)

9 Japan
9.1 Japan Monoclonal Antibody Therapy Market Size (2015-2020)
9.2 Monoclonal Antibody Therapy Key Players in Japan (2019-2020)
9.3 Japan Monoclonal Antibody Therapy Market Size by Type (2015-2020)
9.4 Japan Monoclonal Antibody Therapy Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Monoclonal Antibody Therapy Market Size (2015-2020)
10.2 Monoclonal Antibody Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Monoclonal Antibody Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Monoclonal Antibody Therapy Market Size by Application (2015-2020)

11 India
11.1 India Monoclonal Antibody Therapy Market Size (2015-2020)
11.2 Monoclonal Antibody Therapy Key Players in India (2019-2020)
11.3 India Monoclonal Antibody Therapy Market Size by Type (2015-2020)
11.4 India Monoclonal Antibody Therapy Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Monoclonal Antibody Therapy Market Size (2015-2020)
12.2 Monoclonal Antibody Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Monoclonal Antibody Therapy Market Size by Type (2015-2020)
12.4 Central & South America Monoclonal Antibody Therapy Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Abbvie
13.1.1 Abbvie Company Details
13.1.2 Abbvie Business Overview
13.1.3 Abbvie Monoclonal Antibody Therapy Introduction
13.1.4 Abbvie Revenue in Monoclonal Antibody Therapy Business (2015-2020))
13.1.5 Abbvie Recent Development
13.2 Amgen
13.2.1 Amgen Company Details
13.2.2 Amgen Business Overview
13.2.3 Amgen Monoclonal Antibody Therapy Introduction
13.2.4 Amgen Revenue in Monoclonal Antibody Therapy Business (2015-2020)
13.2.5 Amgen Recent Development
13.3 Glaxosmithkline
13.3.1 Glaxosmithkline Company Details
13.3.2 Glaxosmithkline Business Overview
13.3.3 Glaxosmithkline Monoclonal Antibody Therapy Introduction
13.3.4 Glaxosmithkline Revenue in Monoclonal Antibody Therapy Business (2015-2020)
13.3.5 Glaxosmithkline Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Monoclonal Antibody Therapy Introduction
13.4.4 Merck Revenue in Monoclonal Antibody Therapy Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Monoclonal Antibody Therapy Introduction
13.5.4 Novartis Revenue in Monoclonal Antibody Therapy Business (2015-2020)
13.5.5 Novartis Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Monoclonal Antibody Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Monoclonal Antibody Therapy Revenue
Table 3. Ranking of Global Top Monoclonal Antibody Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Monoclonal Antibody Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Recombinant
Table 6. Key Players of Chimeric
Table 7. Key Players of Humanized
Table 8. Key Players of Human
Table 9. Global Monoclonal Antibody Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Monoclonal Antibody Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Monoclonal Antibody Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Monoclonal Antibody Therapy Market Share by Regions (2015-2020)
Table 13. Global Monoclonal Antibody Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Monoclonal Antibody Therapy Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Monoclonal Antibody Therapy Market Growth Strategy
Table 19. Main Points Interviewed from Key Monoclonal Antibody Therapy Players
Table 20. Global Monoclonal Antibody Therapy Revenue by Players (2015-2020) (Million US$)
Table 21. Global Monoclonal Antibody Therapy Market Share by Players (2015-2020)
Table 22. Global Top Monoclonal Antibody Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Therapy as of 2019)
Table 23. Global Monoclonal Antibody Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Monoclonal Antibody Therapy Product Solution and Service
Table 26. Date of Enter into Monoclonal Antibody Therapy Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Monoclonal Antibody Therapy Market Size by Type (2015-2020) (Million US$)
Table 29. Global Monoclonal Antibody Therapy Market Size Share by Type (2015-2020)
Table 30. Global Monoclonal Antibody Therapy Revenue Market Share by Type (2021-2026)
Table 31. Global Monoclonal Antibody Therapy Market Size Share by Application (2015-2020)
Table 32. Global Monoclonal Antibody Therapy Market Size by Application (2015-2020) (Million US$)
Table 33. Global Monoclonal Antibody Therapy Market Size Share by Application (2021-2026)
Table 34. North America Key Players Monoclonal Antibody Therapy Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Monoclonal Antibody Therapy Market Share (2019-2020)
Table 36. North America Monoclonal Antibody Therapy Market Size by Type (2015-2020) (Million US$)
Table 37. North America Monoclonal Antibody Therapy Market Share by Type (2015-2020)
Table 38. North America Monoclonal Antibody Therapy Market Size by Application (2015-2020) (Million US$)
Table 39. North America Monoclonal Antibody Therapy Market Share by Application (2015-2020)
Table 40. Europe Key Players Monoclonal Antibody Therapy Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Monoclonal Antibody Therapy Market Share (2019-2020)
Table 42. Europe Monoclonal Antibody Therapy Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Monoclonal Antibody Therapy Market Share by Type (2015-2020)
Table 44. Europe Monoclonal Antibody Therapy Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Monoclonal Antibody Therapy Market Share by Application (2015-2020)
Table 46. China Key Players Monoclonal Antibody Therapy Revenue (2019-2020) (Million US$)
Table 47. China Key Players Monoclonal Antibody Therapy Market Share (2019-2020)
Table 48. China Monoclonal Antibody Therapy Market Size by Type (2015-2020) (Million US$)
Table 49. China Monoclonal Antibody Therapy Market Share by Type (2015-2020)
Table 50. China Monoclonal Antibody Therapy Market Size by Application (2015-2020) (Million US$)
Table 51. China Monoclonal Antibody Therapy Market Share by Application (2015-2020)
Table 52. Japan Key Players Monoclonal Antibody Therapy Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Monoclonal Antibody Therapy Market Share (2019-2020)
Table 54. Japan Monoclonal Antibody Therapy Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Monoclonal Antibody Therapy Market Share by Type (2015-2020)
Table 56. Japan Monoclonal Antibody Therapy Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Monoclonal Antibody Therapy Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Monoclonal Antibody Therapy Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Monoclonal Antibody Therapy Market Share (2019-2020)
Table 60. Southeast Asia Monoclonal Antibody Therapy Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Monoclonal Antibody Therapy Market Share by Type (2015-2020)
Table 62. Southeast Asia Monoclonal Antibody Therapy Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Monoclonal Antibody Therapy Market Share by Application (2015-2020)
Table 64. India Key Players Monoclonal Antibody Therapy Revenue (2019-2020) (Million US$)
Table 65. India Key Players Monoclonal Antibody Therapy Market Share (2019-2020)
Table 66. India Monoclonal Antibody Therapy Market Size by Type (2015-2020) (Million US$)
Table 67. India Monoclonal Antibody Therapy Market Share by Type (2015-2020)
Table 68. India Monoclonal Antibody Therapy Market Size by Application (2015-2020) (Million US$)
Table 69. India Monoclonal Antibody Therapy Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Monoclonal Antibody Therapy Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Monoclonal Antibody Therapy Market Share (2019-2020)
Table 72. Central & South America Monoclonal Antibody Therapy Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Monoclonal Antibody Therapy Market Share by Type (2015-2020)
Table 74. Central & South America Monoclonal Antibody Therapy Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Monoclonal Antibody Therapy Market Share by Application (2015-2020)
Table 76. Abbvie Company Details
Table 77. Abbvie Business Overview
Table 78. Abbvie Product
Table 79. Abbvie Revenue in Monoclonal Antibody Therapy Business (2015-2020) (Million US$)
Table 80. Abbvie Recent Development
Table 81. Amgen Company Details
Table 82. Amgen Business Overview
Table 83. Amgen Product
Table 84. Amgen Revenue in Monoclonal Antibody Therapy Business (2015-2020) (Million US$)
Table 85. Amgen Recent Development
Table 86. Glaxosmithkline Company Details
Table 87. Glaxosmithkline Business Overview
Table 88. Glaxosmithkline Product
Table 89. Glaxosmithkline Revenue in Monoclonal Antibody Therapy Business (2015-2020) (Million US$)
Table 90. Glaxosmithkline Recent Development
Table 91. Merck Company Details
Table 92. Merck Business Overview
Table 93. Merck Product
Table 94. Merck Revenue in Monoclonal Antibody Therapy Business (2015-2020) (Million US$)
Table 95. Merck Recent Development
Table 96. Novartis Company Details
Table 97. Novartis Business Overview
Table 98. Novartis Product
Table 99. Novartis Revenue in Monoclonal Antibody Therapy Business (2015-2020) (Million US$)
Table 100. Novartis Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monoclonal Antibody Therapy Market Share by Type: 2020 VS 2026
Figure 2. Recombinant Features
Figure 3. Chimeric Features
Figure 4. Humanized Features
Figure 5. Human Features
Figure 6. Global Monoclonal Antibody Therapy Market Share by Application: 2020 VS 2026
Figure 7. Diagnostic Test Case Studies
Figure 8. Analytical And Chemical Uses Case Studies
Figure 9. Cancer Treatment Case Studies
Figure 10. Autoimmune Diseases Case Studies
Figure 11. Hematological Disorders Case Studies
Figure 12. Monoclonal Antibody Therapy Report Years Considered
Figure 13. Global Monoclonal Antibody Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Monoclonal Antibody Therapy Market Share by Regions: 2020 VS 2026
Figure 15. Global Monoclonal Antibody Therapy Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Monoclonal Antibody Therapy Market Share by Players in 2019
Figure 18. Global Top Monoclonal Antibody Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Therapy as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Monoclonal Antibody Therapy Revenue in 2019
Figure 20. North America Monoclonal Antibody Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Monoclonal Antibody Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Monoclonal Antibody Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Monoclonal Antibody Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Monoclonal Antibody Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Monoclonal Antibody Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Monoclonal Antibody Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed


【掲載企業】

Abbvie、Amgen、Glaxosmithkline、Merck、Novartis

★調査レポート[世界のモノクローナル抗体療法市場インサイト及び予測(~2026年)] (コード:QYR20NV03847)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のモノクローナル抗体療法市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆